comparemela.com

Latest Breaking News On - Genitourinary oncology service - Page 7 : comparemela.com

ViewRay to Host a Virtual Clinical Data Event for Investors and Analysts on March 16, 2022

/PRNewswire/ ViewRay, Inc. (Nasdaq: VRAY) announced today that the company will host a Virtual Clinical Data Event for Investors and Analysts on Wednesday,.

New yorkUnited statesHimanshu nagarAmar kishanExchange commissionGenitourinary oncology servicePrnewswire viewray incViewray incVirtual clinical data eventAssociate professorAssistant professorWeill cornell medicineNew york presbyterianGuided radiation therapyPrivate securities litigation reformLinac system

Interim Findings from MIRAGE Phase III Randomized Trial Signal Superiority of MRIdian® MRI-guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer

/PRNewswire/ ViewRay, Inc. (NASDAQ: VRAY) today announced that interim data from the single center Phase III randomized MIRAGE trial, led by UCLA, comparing.

United statesSan franciscoKishan amarukishanAmar kishanPrnewswire viewray incAmerican society of clinical oncologyDepartment of defenseNational institutes of healthInternational prostate symptom scoreVarian medical systems incGenitourinary oncology serviceAmerican society for radiation oncologyViewray incJonsson comprehensive cancer foundationProstate cancer foundationClinical oncology

UCLA in the News January 4, 2022

Highlights from the New York Post, BuzzFeed, Discover and others.

New yorkUnited statesLos angelesAmar kishanTerence taoElizabeth holmesDiane birnholzMichael stollAngelique campenVickie maysRobert kim farleyUniversity of californiaUniversity of california at los angelesLos angeles timesNew york postFielding school of public health

Black Men Get Better Outcomes From Radiation Rx for Prostate Cancer

While Black men are often diagnosed later than white men, radiation therapy seems to work better for them than for their white peers.

United statesSalt lake cityUniversity of utahLos angelesNeeraj agarwalAmar kishanUniversity of californiaGenitourinary oncology serviceHuntsman cancer instituteClinical research innovationDepartment of radiation oncologyTranslational researchWhile blackRadiation oncologySalt lake

Black Men Get Better Outcomes From Radiation Rx for Prostate Cancer

MONDAY, Jan. 3, 2022 (HealthDay News) A new analysis uncovers a racial paradox in prostate cancer care: While Black men are often diagnosed later and with more aggressive disease

New yorkUnited statesSalt lake cityUniversity of utahLos angelesMadhur gargNeeraj agarwalAmar kishanOtis brawleyUniversity of californiaMontefiore health systemHuntsman cancer instituteClinical research innovationJohns hopkins university school of medicineGenitourinary oncology serviceTranslational research

vimarsana © 2020. All Rights Reserved.